188 related articles for article (PubMed ID: 3417226)
1. Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease.
Guigui B; Perrot S; Berry JP; Fleury-Feith J; Martin N; Métreau JM; Dhumeaux D; Zafrani ES
Hepatology; 1988; 8(5):1063-8. PubMed ID: 3417226
[TBL] [Abstract][Full Text] [Related]
2. Amiodarone-induced hepatic phospholipidosis: correlation of morphological and biochemical findings in an animal model.
Pirovino M; Müller O; Zysset T; Honegger U
Hepatology; 1988; 8(3):591-8. PubMed ID: 3371876
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic analysis of suspected amiodarone hepatotoxicity.
Lewis JH; Mullick F; Ishak KG; Ranard RC; Ragsdale B; Perse RM; Rusnock EJ; Wolke A; Benjamin SB; Seeff LB
Hum Pathol; 1990 Jan; 21(1):59-67. PubMed ID: 2403975
[TBL] [Abstract][Full Text] [Related]
4. Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.
Poucell S; Ireton J; Valencia-Mayoral P; Downar E; Larratt L; Patterson J; Blendis L; Phillips MJ
Gastroenterology; 1984 May; 86(5 Pt 1):926-36. PubMed ID: 6706074
[TBL] [Abstract][Full Text] [Related]
5. Increased hepatic density and phospholipidosis due to amiodarone.
Goldman IS; Winkler ML; Raper SE; Barker ME; Keung E; Goldberg HI; Boyer TD
AJR Am J Roentgenol; 1985 Mar; 144(3):541-6. PubMed ID: 3871563
[TBL] [Abstract][Full Text] [Related]
6. Chronic liver disease after low daily doses of amiodarone. Report of three cases.
Babany G; Mallat A; Zafrani ES; Saint-Marc Girardin MF; Carcone B; Dhumeaux D
J Hepatol; 1986; 3(2):228-32. PubMed ID: 3794303
[TBL] [Abstract][Full Text] [Related]
7. X-ray microanalysis of cultured alveolar macrophages with phospholipidosis.
Lee P; Kirk RG; Reasor MJ
Exp Mol Pathol; 1993 Apr; 58(2):96-104. PubMed ID: 8388333
[TBL] [Abstract][Full Text] [Related]
8. Silymarin and vitamin E reduce amiodarone-induced lysosomal phospholipidosis in rats.
Agoston M; Orsi F; Fehér E; Hagymási K; Orosz Z; Blázovics A; Fehér J; Vereckei A
Toxicology; 2003 Aug; 190(3):231-41. PubMed ID: 12927377
[TBL] [Abstract][Full Text] [Related]
9. Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone.
Natale A; Boeckmans J; Desmae T; De Boe V; De Kock J; Vanhaecke T; Rogiers V; Rodrigues RM
Toxicol Lett; 2018 Mar; 284():184-194. PubMed ID: 29248575
[TBL] [Abstract][Full Text] [Related]
10. High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis.
van de Water FM; Havinga J; Ravesloot WT; Horbach GJ; Schoonen WG
Toxicol In Vitro; 2011 Dec; 25(8):1870-82. PubMed ID: 21651975
[TBL] [Abstract][Full Text] [Related]
11. Assessment of amiodarone-induced phospholipidosis in chimeric mice with a humanized liver.
Sanoh S; Yamachika Y; Tamura Y; Kotake Y; Yoshizane Y; Ishida Y; Tateno C; Ohta S
J Toxicol Sci; 2017; 42(5):589-596. PubMed ID: 28904294
[TBL] [Abstract][Full Text] [Related]
12. Double Hit of Hydroxichloroquine and Amiodarone Induced Renal Phospholipidosis in a Patient with Monoclonal Gammopathy and Sclerodermiform Syndrome: A Case Report and Review of the Literature.
De la Flor JC; Rodríguez-Doyágüez P; Villa D; Zamora R; Díaz F
Med Sci (Basel); 2024 May; 12(2):. PubMed ID: 38804381
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers to monitor drug-induced phospholipidosis.
Baronas ET; Lee JW; Alden C; Hsieh FY
Toxicol Appl Pharmacol; 2007 Jan; 218(1):72-8. PubMed ID: 17156806
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Phospholipidosis Is Associated with Altered Hepatobiliary Function as Assessed by Gadoxetate Dynamic Contrast-enhanced Magnetic Resonance Imaging.
Lenhard SC; Lev M; Webster LO; Peterson RA; Goulbourne CN; Miller RT; Jucker BM
Toxicol Pathol; 2016 Jan; 44(1):51-60. PubMed ID: 26516164
[TBL] [Abstract][Full Text] [Related]
15. Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines.
Ploemen JP; Kelder J; Hafmans T; van de Sandt H; van Burgsteden JA; Saleminki PJ; van Esch E
Exp Toxicol Pathol; 2004 Mar; 55(5):347-55. PubMed ID: 15088636
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone induced phospholipidosis. Biochemical, morphological and functional changes in the lungs of rats chronically treated with amiodarone.
Riva E; Marchi S; Pesenti A; Bizzi A; Cini M; Veneroni E; Tavbani E; Boeri R; Bertani T; Latini R
Biochem Pharmacol; 1987 Oct; 36(19):3209-14. PubMed ID: 3663236
[TBL] [Abstract][Full Text] [Related]
17. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
Reasor MJ
Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):169-81. PubMed ID: 1876748
[TBL] [Abstract][Full Text] [Related]
18. Granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study.
Shepherd NA; Dawson AM; Crocker PR; Levison DA
J Clin Pathol; 1987 Apr; 40(4):418-23. PubMed ID: 3584485
[TBL] [Abstract][Full Text] [Related]
19. Morphological and biochemical changes in the liver of various species in experimental phospholipidosis after diethylaminoethoxyhexestrol treatment.
de la Iglesia FA; Feuer G; McGuire EJ; Takada A
Toxicol Appl Pharmacol; 1975 Oct; 34(1):28-44. PubMed ID: 1198614
[No Abstract] [Full Text] [Related]
20. Amiodarone hepatotoxicity.
Elving LD; Hoefnagels WH; Van Haelst UJ; Griffioen G; Janssens AR; Ruiter DJ
Neth J Med; 1986; 29(10):303-7. PubMed ID: 3796766
[No Abstract] [Full Text] [Related]
[Next] [New Search]
